GSA Capital Partners’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.71M | Sell |
|
|||||
|
2025
Q2 | $1.43M | Sell |
|
|||||
|
2025
Q1 | $485K | Buy |
|
|||||
|
2024
Q4 | $40K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $279K | Buy |
|
|||||
|
2024
Q1 | $324K | Buy |
|
|||||
|
2023
Q4 | $161K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $592K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.27M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $148K | Sell |
|
|||||
|
2020
Q4 | $209K | Buy |
|
|||||
|
2020
Q3 | $188K | Sell |
|
|||||
|
2020
Q2 | $339K | Sell |
|
|||||
|
2020
Q1 | $471K | Sell |
|
|||||
|
2019
Q4 | $968K | Buy |
|
|||||
|
2019
Q3 | $576K | Buy |
|
|||||
|
2019
Q2 | $737K | Buy |
|
|||||
|
2019
Q1 | $383K | Buy |
|
|||||
|
2018
Q4 | $524K | Sell |
|
|||||
|
2018
Q3 | $646K | Sell |
|
|||||
|
2018
Q2 | $1.14M | Buy |
|
|||||
|
2018
Q1 | $251K | Buy |
|